Laquinimod, a new oral drug for multiple sclerosis.
Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA. keegan.bmark@mayo.edu
B Mark
BM
Keegan
Brian G
BG
Weinshenker
D000284:Administration, Oral; D006801:Humans; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000188:drug therapy* / Q000503:physiopathology; D015363:Quinolones / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D015363:Quinolones; C476223:laquinimod